Pages

▼
Showing posts with label Pfizer. Show all posts
Showing posts with label Pfizer. Show all posts
30 July 2014

Pfizer:: Rating: Buy; Target Price: Rs1,810; Centrum

›
Rating: Buy; Target Price: Rs1,810; CMP: Rs1,372; Upside: 31.9% Wyeth’s performance strong We maintain Buy rating on Pfizer with a target ...
03 March 2014

Pfizer - Event Update - Internal Corporate Restructuring - positive :Centrum

›
Rating: Buy; Target Price: Rs1,600; CMP: Rs1,141; Upside: 40.2% Internal Corporate Restructuring - positive We maintain Buy rating on Pfiz...
01 December 2013

Pfizer - Wyeth Merger :Centrum

›
Rating: Buy; Target Price: Rs1,530; CMP: Rs1,605; Upside (ex-interim.div.) 22.9% Set to derive synergies of merger We maintain Buy rating ...
09 August 2013

Pfizer - Q1FY14 results update - Centrum

›
Strong margin improvement Pfizer’s revenues and EBIDTA for Q1FY14 were marginally below our expectations but net profit was in line. The...
05 June 2013

On a growth path Pfizer :: Centrum

›
On a growth path Pfizer’s results for Q4FY13 were better than our expectations. The company reported a growth of 3%YoY in revenues, 60bps...
13 February 2013

Pfizer, Q3FY13 Result Update :: Centrum

›
Disappointing results Pfizer reported disappointing results for Q3FY13, showing a decline of 5%YoY in revenues, 370bps in EBIDTA margin ...
14 November 2012

Margin improves Pfizer results Q2FY13: :: Centrum

›
Margin improves Pfizer results for Q2FY13 were in line with our expectations. The company reported 7%YoY decline in revenues, 500bps im...
05 September 2012

Pfizer India - Riding the brandwagon; Initiating with a Buy :: anand rathi,

›
Pfizer India Riding the brandwagon; Initiating with a Buy Continued support from a strong parent and brand equity are Pfizer’s backbon...
03 September 2012

Pfizer :Slower sales growth affects results :Centrum

›
Slower sales growth affects results Pfizer results for Q1FY13 were lower than our expectations. The company reported 7%YoY decline in r...
17 April 2012

PFIZER INDIA : Target 1,771 :: Anand Rathi

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� ...
17 March 2012

Biocon: Biocon-Pfizer deal off :: Kotak Securities PDF Link

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� htt...
30 January 2012

Q3FY12 Result Update Pfizer Buy Target Price: Rs1,483 ::Centrum

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� Q...
10 November 2011

Pfizer Ltd Growth trajectory intact - Maintain Accumulate :Emkay,

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� ...
01 November 2011

Pfizer's branded generics: Would the end be as strong as the beginning?:: Credit Suisse

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� ● ...
09 August 2011

Pfizer Ltd Sustainable growth trajectory - Maintain Accumulate ::Emkay

›
Please Share:: India Equity Research Reports, IPO and Stock News Visit http://indiaer.blogspot.com/ for complete details �� �� ...
20 October 2010

Biocon : increase PT to Rs430, maintain BUY. says Kotak Securities

›
Visit http://indiaer.blogspot.com/ for complete details 􀂄 􀂄 Biocon monetizes its insulin portfolio, out licensing of oral insuli...
16 October 2010

Religare on Pfizer: Heading for a stronger & sustainable growth trajectory

›
Visit http://indiaer.blogspot.com/ for complete details 􀂄 􀂄 Pfizer Ltd Heading for a stronger & sustainable growth trajecto...
08 October 2010

Emkay: Pfizer Ltd Downgrade earnings estimates

›
Pfizer Ltd Downgrade earnings estimates; Maintain Hold Hold CMP: Rs 1,093                                       Target Price: Rs ...